The penetrance of the mutant APOB allele, however, is not 100%, so patients with familial ligand-defective apoB have a less-severe phenotypes than FH (Familial Hypercholesterolemia) patients with a LDLR mutation [43, 44]. This evidence concerns the gene APOB and familial hypercholesterolemia.